ARTICLE | Clinical News
Vascular Targeting Agent technology regulatory update
March 20, 2000 8:00 AM UTC
TCLN received U.S. Patent No. 6,036,955 covering methods of inducing molecules on tumor blood vessels for subsequent targeting and destruction. The patent relates to the company's Vascular Targeting A...